ACE Inhibitor Dosing for Hypertension and Heart Failure
For hypertension, start lisinopril at 10 mg once daily and titrate to a target of 20-40 mg daily; for heart failure, start at 2.5-5 mg once daily and aggressively titrate to the target dose of 30-35 mg daily, as higher doses significantly reduce mortality and hospitalizations. 1, 2, 3
Hypertension Dosing
- Initial dose: 10 mg once daily in treatment-naive patients 1, 2
- Initial dose: 5 mg once daily if patient is already on diuretics 1
- Titrate at 2-week intervals based on blood pressure response 2, 1
- Target maintenance dose: 20-40 mg once daily 4, 1
- Doses up to 80 mg have been studied but provide no additional benefit 1
Heart Failure Dosing
The evidence strongly supports aggressive up-titration to high doses in heart failure patients:
- Initial dose: 5 mg once daily when used with diuretics and digoxin 1, 4
- Initial dose: 2.5 mg once daily if hyponatremia present (serum sodium <130 mEq/L) 1, 3
- Target dose: 30-35 mg once daily 2, 3, 4
- Maximum dose: 40 mg once daily 1, 4
Critical Evidence on Dose-Response
The ATLAS trial definitively demonstrated that high doses (32.5-35 mg daily) are superior to low doses (2.5-5 mg daily) in heart failure patients: 5, 6
- 12% reduction in death or hospitalization (p=0.002) 5, 3
- 24% reduction in heart failure hospitalizations (p=0.002) 5, 6
- 8% reduction in all-cause mortality (p=0.128, not statistically significant but clinically meaningful) 5
Common pitfall: Many clinicians fail to titrate to target doses and leave patients on subtherapeutic doses of 5-10 mg daily, missing substantial clinical benefits 3, 5
Post-Myocardial Infarction Dosing
For hemodynamically stable patients within 24 hours of MI: 1, 3
- Day 1: 5 mg orally
- Day 2: 5 mg
- Day 3: 10 mg
- Maintenance: 10 mg once daily for at least 6 weeks
- If low systolic BP (100-120 mmHg): Start with 2.5 mg 1
Renal Dose Adjustments
- CrCl >30 mL/min: No adjustment needed 1
- CrCl 10-30 mL/min: Start at half the usual dose (hypertension: 5 mg; heart failure: 2.5 mg) 1
- CrCl <10 mL/min or hemodialysis: Start at 2.5 mg once daily 1
Monitoring Protocol
Initial monitoring (critical for safety): 2, 3
- Check renal function and potassium 1-2 weeks after initiation 4, 2
- Recheck 1-2 weeks after each dose increase 2, 3
- Monitor at 3 months, then every 6 months 2, 3
Acceptable laboratory changes during titration: 2, 3
- Creatinine increase up to 50% above baseline OR to 3 mg/dL (whichever is greater) is acceptable 2, 3
- Potassium up to 5.5 mEq/L is generally manageable 4
Titration Strategy
The key principle: Titrate to target dose, not to symptomatic response 4
- Double the dose every 2 weeks if tolerated 4, 2
- Aim for target doses proven in clinical trials (30-35 mg for heart failure, 20-40 mg for hypertension) 4, 2
- If target dose not tolerated, use the highest tolerated dose 4, 3
- Small differences exist between intermediate and high doses, but low doses are clearly inferior 5
Important Precautions
Avoid during titration: 3
- NSAIDs and COX-2 inhibitors (worsen renal function and reduce efficacy) 3
- Potassium-sparing diuretics unless specifically needed for persistent hypokalemia 3
Cautions requiring specialist consultation: 4
- Systolic BP <80 mmHg 4
- Serum creatinine >3 mg/dL at baseline 4
- Bilateral renal artery stenosis 4
- Serum potassium >5.0 mEq/L at baseline 4
Absolute contraindications: 4
Managing Adverse Effects
ACE inhibitor-induced cough: 3
- Rarely requires discontinuation 3
- Only switch to ARB if cough is proven ACE inhibitor-related through withdrawal and rechallenge 3
Hypotension during titration: 4